Clinical Trial

Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial

Study acronym: SENS-eAD
Completed
View on ClinicalTrials.gov →
Summary
Estimate the safty and efficacy of personalized network neuronavigated transcranial magnetic stimulations in early Alzheimer's disease patients
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-16; most recent amendment 2026-06-11.
Status change: Recruiting → Completed 2026-06-11
Trial Details
NCT Number NCT07138677
Lead Sponsor Anhui Medical University
Conditions Alzheimer's Disease, Transcranial Magnetic Stimulation, Individualized Navigation
Enrollment 40 participants
Start Date 2025-07-20
Primary Completion 2026-03-14 (estimated)
Study Completion 2026-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-06-12